<html><head></head><body><h1>Danyelza</h1><p>Generic Name: naxitamab-gqgk<br/>
Dosage Form: injection, for intravenous use</p><ul class="ddc-anchor-links"><li>Warnings</li>
<li>Uses</li>
<li>Side effects</li></ul><h2 class="ddc-anchor-offset" id="warnings">Warnings</h2><p>Danyelza may cause serious side effects, including:</p><ul>
<li><strong>Serious infusion-related reactions.</strong> Danyelza can cause serious infusion-related reactions that require immediate medical attention. Infusion-related reactions are common with Danyelza. Tell your healthcare provider right away if you get any signs or symptoms during or after your infusion, including:
<ul>
<li>swelling of your face, eyes, lips, mouth, or tongue</li>
<li>itching</li>
<li>redness on your face (flushing)</li>
<li>skin rash or hives</li>
<li>trouble breathing</li>
<li>cough or wheezing</li>
<li>noisy high-pitched breathing</li>
<li>feeling faint or dizziness (low blood pressure)</li>
</ul>
</li>
<li><strong>Nervous system problems.</strong> Talk to your healthcare provider right away if you have new symptoms or worsening of nervous system problems, including:
<ul>
<li><strong>Severe pain from nerves (neuropathic pain)</strong>, including pain in the belly (abdomen), bone, neck, legs or arms. Pain is common with Danyelza and can be severe.</li>
<li><strong>Inflammation of the spinal cord.</strong> Signs or symptoms may include:
<ul>
<li>weakness in your legs or arms</li>
<li>bladder and bowel problems</li>
<li>pain in back, legs, or stomach (abdomen)</li>
<li>numbness</li>
<li>tingling</li>
<li>burning sensation</li>
</ul>
</li>
<li><strong>Reversible Posterior Leukoencephalopathy Syndrome (RPLS – also known as Posterior Reversible</strong> <strong>Encephalopathy Syndrome - PRES).</strong> PRES is a condition that affects the brain. Your healthcare provider will monitor your blood pressure and check for any neurologic symptoms after your infusion. Signs or symptoms of PRES may include:
<ul>
<li>severe headache</li>
<li>vision changes</li>
<li>changes in mental status, such as confusion, disorientation, or decreased alertness</li>
<li>difficulty speaking</li>
<li>weakness in your arms or legs</li>
<li>seizures</li>
</ul>
</li>
<li><strong>Numbness, tingling, or burning sensation in the arms or legs.</strong></li>
<li><strong>Nervous system problems of the eye.</strong> Signs or symptoms may include:
<ul>
<li>unequal pupil size</li>
<li>blurred vision</li>
<li>trouble focusing your eyes</li>
<li>larger pupil size (dilated)</li>
<li>decreased ability to see</li>
<li>sensitivity to light</li>
</ul>
</li>
<li><strong>Problems urinating or emptying your bladder (prolonged urinary retention).</strong></li>
</ul>
</li>
</ul><ul>
<li>swelling of your face, eyes, lips, mouth, or tongue</li>
<li>itching</li>
<li>redness on your face (flushing)</li>
<li>skin rash or hives</li>
<li>trouble breathing</li>
<li>cough or wheezing</li>
<li>noisy high-pitched breathing</li>
<li>feeling faint or dizziness (low blood pressure)</li>
</ul><ul>
<li><strong>Severe pain from nerves (neuropathic pain)</strong>, including pain in the belly (abdomen), bone, neck, legs or arms. Pain is common with Danyelza and can be severe.</li>
<li><strong>Inflammation of the spinal cord.</strong> Signs or symptoms may include:
<ul>
<li>weakness in your legs or arms</li>
<li>bladder and bowel problems</li>
<li>pain in back, legs, or stomach (abdomen)</li>
<li>numbness</li>
<li>tingling</li>
<li>burning sensation</li>
</ul>
</li>
<li><strong>Reversible Posterior Leukoencephalopathy Syndrome (RPLS – also known as Posterior Reversible</strong> <strong>Encephalopathy Syndrome - PRES).</strong> PRES is a condition that affects the brain. Your healthcare provider will monitor your blood pressure and check for any neurologic symptoms after your infusion. Signs or symptoms of PRES may include:
<ul>
<li>severe headache</li>
<li>vision changes</li>
<li>changes in mental status, such as confusion, disorientation, or decreased alertness</li>
<li>difficulty speaking</li>
<li>weakness in your arms or legs</li>
<li>seizures</li>
</ul>
</li>
<li><strong>Numbness, tingling, or burning sensation in the arms or legs.</strong></li>
<li><strong>Nervous system problems of the eye.</strong> Signs or symptoms may include:
<ul>
<li>unequal pupil size</li>
<li>blurred vision</li>
<li>trouble focusing your eyes</li>
<li>larger pupil size (dilated)</li>
<li>decreased ability to see</li>
<li>sensitivity to light</li>
</ul>
</li>
<li><strong>Problems urinating or emptying your bladder (prolonged urinary retention).</strong></li>
</ul><ul>
<li>weakness in your legs or arms</li>
<li>bladder and bowel problems</li>
<li>pain in back, legs, or stomach (abdomen)</li>
<li>numbness</li>
<li>tingling</li>
<li>burning sensation</li>
</ul><ul>
<li>severe headache</li>
<li>vision changes</li>
<li>changes in mental status, such as confusion, disorientation, or decreased alertness</li>
<li>difficulty speaking</li>
<li>weakness in your arms or legs</li>
<li>seizures</li>
</ul><ul>
<li>unequal pupil size</li>
<li>blurred vision</li>
<li>trouble focusing your eyes</li>
<li>larger pupil size (dilated)</li>
<li>decreased ability to see</li>
<li>sensitivity to light</li>
</ul><h2 class="ddc-anchor-offset" id="uses">What is Danyelza?</h2><p>Danyelza is a prescription medicine used in combination with a medicine called granulocyte-macrophage colony stimulating factor (GM-CSF) to treat children 1 year of age and older and adults with high-risk neuroblastoma in the bone or bone marrow that:</p><ul>
<li>has come back (relapsed) or that did not respond to previous treatment (refractory), and</li>
<li>has shown a partial response, minor response, or stable disease to prior therapy.</li>
</ul><h2>Who should not receive Danyelza?</h2><p>You should not receive Danyelza if you have had a severe allergic reaction to naxitamab-gqgk, the active ingredient. Ask your healthcare provider if you are not sure.</p><h2>Before receiving Danyelza</h2><p>Before receiving Danyelza, tell your healthcare provider about all your medical conditions, including if you:</p><ul>
<li>have high blood pressure</li>
<li>are pregnant or plan to become pregnant. Danyelza may harm your unborn baby.
<ul>
<li>Your healthcare provider will do a pregnancy test before you start treatment.</li>
<li>Females who are able to become pregnant should use effective birth control (contraception) during treatment and for 2 months after your last dose. Talk to your healthcare provider about birth control choices that may be right for you during this time.</li>
<li>Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment.</li>
</ul>
</li>
<li>are breastfeeding or plan to breastfeed. It is not known if Danyelza passes into your breast milk. Do not breastfeed during treatment and for 2 months after your last dose.</li>
</ul><ul>
<li>Your healthcare provider will do a pregnancy test before you start treatment.</li>
<li>Females who are able to become pregnant should use effective birth control (contraception) during treatment and for 2 months after your last dose. Talk to your healthcare provider about birth control choices that may be right for you during this time.</li>
<li>Tell your healthcare provider right away if you become pregnant or think you might be pregnant during treatment.</li>
</ul><p>Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.</p><h2>How will I receive Danyelza?</h2><ul>
<li>Your healthcare provider will give you Danyelza into your vein through an intravenous (I.V.) line over a minimum of 30 or 60 minutes.</li>
<li>Danyelza is given on Days 1, 3, and 5 of each treatment cycle.</li>
<li>Danyelza is used with another medicine called GM-CSF. You can ask your healthcare provider for information about GM-CSF.</li>
<li>Danyelza treatment cycles are usually repeated every 4 or 8 weeks. Your healthcare provider will decide how many treatment cycles you need.</li>
<li>Your healthcare provider will give you certain medicines before and during your infusion to help decrease your risk of getting pain, infusion-related reactions, and nausea or vomiting.</li>
<li>Your healthcare provider may slow down your infusion rate, temporarily stop the infusion, or permanently stop treatment if you have certain side effects.</li>
<li>You will be monitored for side effects for at least 2 hours after each infusion.</li>
<li>If you miss an appointment, call your healthcare provider as soon as possible to reschedule.</li>
</ul><h2 class="ddc-anchor-offset" id="side-effects">Danyelza side effects</h2><p>Danyelza may cause serious side effects, including:</p><ul>
<li>See <em>Important information</em></li>
<li><strong>High blood pressure (hypertension).</strong> High blood pressure is common in people who receive Danyelza. Your blood pressure will be monitored during your Danyelza infusion, and at least each day on Days 1 to 8 of each treatment cycle. Tell your healthcare provider right away if you get any signs or symptoms of high blood pressure, including:
<ul>
<li>headaches</li>
<li>seizures</li>
<li>nausea or vomiting</li>
<li>chest pain</li>
<li>dizziness</li>
<li>visual changes</li>
<li>shortness of breath</li>
<li>feeling that your heart is pounding or racing (palpitations)</li>
<li>nose bleeds</li>
</ul>
</li>
</ul><ul>
<li>headaches</li>
<li>seizures</li>
<li>nausea or vomiting</li>
<li>chest pain</li>
<li>dizziness</li>
<li>visual changes</li>
<li>shortness of breath</li>
<li>feeling that your heart is pounding or racing (palpitations)</li>
<li>nose bleeds</li>
</ul><p>The most common side effects include:</p><ul>
<li>fast heart rate</li>
<li>vomiting</li>
<li>cough</li>
<li>nausea</li>
<li>decreased white blood cell, red blood cell, and platelet counts</li>
<li>diarrhea</li>
<li>decreased appetite</li>
<li>tiredness</li>
<li>skin rashes</li>
<li>decreased level of potassium, sodium, and phosphate in the blood</li>
<li>hives</li>
<li>fever</li>
<li>headache</li>
<li>injection site reaction</li>
<li>swelling of the body or only in one part of the body</li>
<li>anxiety</li>
<li>irritability</li>
<li>increased liver function blood tests</li>
<li>decreased blood sugar level</li>
<li>decreased calcium levels in the blood</li>
<li>decreased protein levels (albumin) in the blood</li>
</ul><p>These are not all of the possible side effects of Danyelza.<br/>
<br/>
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.</p><h2>General information about the safe and effective use of Danyelza.</h2><p>Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your pharmacist or healthcare provider for information that is written for health professionals.</p><h2>What are the ingredients in Danyelza?</h2><p><strong>Active ingredient:</strong> naxitamab-gqgk<br/>
<strong>Inactive ingredients:</strong> citric acid anhydrous, poloxamer 188, sodium chloride, sodium citrate, water for Injection; USP.</p><h2>More about Danyelza (naxitamab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antineoplastics</li>
<li>FDA Approval History</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Neuroblastoma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>